# Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder

> **NCT00034580** · PHASE4 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 326 (—)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** olanzapine
- **DRUG:** risperidone

## Key facts

- **NCT ID:** NCT00034580
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-08
- **Primary completion:** —
- **Final completion:** 2002-08
- **Target enrollment:** 326 (—)
- **Last updated:** 2006-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00034580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00034580, "Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00034580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*